[MO34-4] Comparative study on the efficacy and exposure of molecular target agents in NSCLC PDX models with driver mutations
Abstract password authentication.
The password can be found on page 27 of the program book.
Mini-Oral Session
Sat. Feb 19, 2022 2:00 PM - 2:40 PM Room 5 (Room B-1, 2F, Kyoto International Conference Center)
Chair:Toshio Shimizu(Early Phase 1 Drug Development Service, Department of Experimental Therapeutics, National Cancer Center Hospital),Yoshihiko Segawa(Department of Medical Oncology, International Medical Center, Saitama Medical University)
Abstract password authentication.
The password can be found on page 27 of the program book.